Global /China /Healthcare /Biotechnology /301520

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

301520

• SHE: 301520 • Delayed

42.46CNY 0.9%

6.27 USD

As of 15 June 2026, Anhui Wanbang Pharmaceutical Technology Co.,Ltd. has a market cap of $415.74M USD, ranking #16413 globally and #5141 in China. It ranks #1481 in the Healthcare sector, and #288 in the Biotechnology industry.

Global Rank

16413

Country Rank

5141

Sector Rank

1481

Industry Rank

288

Key Stats

Market Cap

$415.74MUSD

2.81B CNY

Enterprise Value

$244.38MUSD

1.65B CNY

Revenue (TTM)

$34.53MUSD

233.67M CNY

EBITDA (TTM)

$2.95MUSD

19.97M CNY

Net Income (TTM)

$3.59MUSD

24.32M CNY

EBITDA Margin

8.5%

Profit Margin

10%

PE Ratio

116.2

PS Ratio

12.0

EV/EBITDA

82.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Chunlei Tao open_in_new

Employees

362

Founded

2006

Website

ahwbyy.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.9%	-3.6%	1.9%	-4.3%	-2.7%	6%	18%	-48%	-48%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301520 安徽万邦医药科技股份有限公司 Class A Shares ISIN: CNE1000068J8 Shares Out.: Shares Outstanding: 21.561M¹ Shares Float: 14.798M² TV: TradingView: SZSE: 301520 SA: Stock Analysis: SHE: 301520 YF: Yahoo Finance: 301520.SZ GF: Google Finance: SHE: 301520 BA: Barron's: 301520 MS: Morningstar: XSHE: 301520	42.46 CNY	TV: TradingView: SZSE: 301520 SA: Stock Analysis: SHE: 301520 YF: Yahoo Finance: 301520.SZ GF: Google Finance: SHE: 301520 BA: Barron's: 301520 MS: Morningstar: XSHE: 301520

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. provides pharmaceutical research and clinical research services in China. The company offers service platform for pharmaceutical research, raw materials, clinical research, medical device services, biological sample analysis, SMO service, and statistical analysis. It also provides precision nutrition cooperation and ecosystem platform; and drug platform. The company was incorporated in 2006 and is based in Hefei, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.45B 136.71B HKD 4K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 3K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.01B 54.23B CNY 2K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.34B 49.69B CNY 2K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 2K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.73B 45.52B CNY 2K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 44K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 38K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 11K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.92B 68.19T KRW 11K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.46B 60.27B AUD 10K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 10K%	37.2	Switzerland

chevron_leftBack